ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 100290 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 100290; 2) Community: the network communities that were significantly associated with the response to NSC 100290; 3) Molecule: the relationships between components within communities and NSC 100290; 4) MDR: the compounds that were significantly associated with the NSC 100290.

NSC Compound Enrichment Correlation
NSC 639498 Cyclopentanone, 2-[(dimethylamino)methyl]-5-(2-methyl- propylidene)-, hydrochloride 0.0314734733353265 0.26568538
NSC 651654 Null 0.0314734733353265 0.32273268
NSC 652174 Null 0.0314734733353265 0.14401538
NSC 664529 Null 0.0314734733353265 0.36065689
NSC 666160 Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) 0.0314734733353265 0.51651734
NSC 670312 Null 0.0314734733353265 0.23673974
NSC 680935 2H-Furo[3',2':3,4]benzopyrano[6,7-b]pyridine- 2,6,11-trione, 2,3-dihydro-5,5,8-trimethyl- 0.0314734733353265 0.2698634
NSC 681640 Camptothecin Derivative 0.0314734733353265 0.4193096
NSC 681642 Camptothecin Derivative 0.0314734733353265 0.359448
NSC 682689 2,4,16-Tribromoestra-1,3,5(10)-trien-3-ol-17-one 0.0314734733353265 0.34827774
Total:173  Current:138    [First] [Prev] [Next] [Last]